Evidence map›Paper›PMID 41292754›Full record

ArticlebioRxiv : the preprint server for biology2025

The crystal structure of the activin B:Fst288 complex and computational insights into the broad antagonistic activity and specificity of follistatin.

Lucija Hok, Ryan G Walker, James A Howard, Eleanor M Mast, Chandramohan Kattamuri, Erich J Goebel, Thomas B Thompson

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Lucija HokDepartment of Molecular & Cellular Biosciences, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.ORCID 0000-0003-0731-1293
Ryan G WalkerDepartment of Molecular & Cellular Biosciences, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.ORCID 0000-0001-6160-8026
James A HowardDepartment of Pharmacology & Systems Physiology, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.ORCID 0000-0001-5020-9687
Eleanor M MastDepartment of Molecular & Cellular Biosciences, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.ORCID 0000-0002-6744-6985
Chandramohan KattamuriDepartment of Molecular & Cellular Biosciences, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.ORCID 0000-0001-9794-3248
Erich J GoebelDepartment of Molecular & Cellular Biosciences, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.ORCID 0000-0001-5549-9425
Thomas B ThompsonDepartment of Molecular & Cellular Biosciences, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.ORCID 0000-0002-7041-5047

Funding

Structural/functional characterization of TGFβ superfamily signaling and regulationR35GM134923 · NIGMS · UNIVERSITY OF CINCINNATI · PI THOMPSON, THOMAS B · 2020 to 2024
$2.6M
NIGMS NIH HHS R35 GM134923
6 · The paper itself

Abstract

Members of the TGF-β family regulate diverse biological processes, and their activity is tightly controlled by extracellular antagonists such as follistatin 288 (Fst288). Fst288 potently inhibits activins A and B, GDF8, and GDF11. Among these, ActB is the least structurally and functionally characterized, which limits a full understanding of Fst288's broad activity and its specificity for this TGF-β subgroup. To address this, we solved the crystal structure of the ActB:Fst288 complex. As in other complexes, two Fst288 molecules surround ActB, occluding both receptor-binding sites. However, ActB engages Fst288 differently: its fingers bind most strongly the ND domain, while its acidic fingertips uniquely contact FSD3 disrupting interactions between the two Fst288 molecules and reducing the cooperativity seen in other complexes. Computational analysis revealed that, although ActB exhibits higher interaction enthalpy, entropic penalty lowers its overall affinity compared to ActA, consistent with experimentally measured

Indexed as

Activin B (ActB)follistatin 288 (Fst288)molecular dynamics simulations (MDS)transforming growth factor beta family (TGF-β)X-ray crystallography

Identifiers

PMID41292754
PMCPMC12642644

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.